Patenting Antibody and Cell Therapies – What to Do and What Not to Do

In Webinars

28 September, 2020

Click here to watch webinar.

Antibody drugs and cell therapies are at the heart of new biotechnology science. Not only do they show great promise when it comes to curing disease and helping patients, but also in creating value and growth. Biotech companies need to protect their scientific results and the corresponding investments with strong and durable patents. This is a complex task, with constantly evolving case law and practice on both sides of the Atlantic. In this webinar, AWA’s experts focus on how to create, defend and litigate these patents in Europe and elsewhere.

 

 

You may also be interested in:

All eyes on Germany as UPC is resuscitated at Bundestag and Bundesrat

German ratification of the UPCA is one of the last hurdles for the Unitary Patent system. The system has

Read more...

IP Strategy

  In this fifth and final webinar in this series Anders Heebøll-Nielsen talks about the importance of creating an

Read more...

Design Protection

  Maria Dam Jørgensen and Eva Carlsson explain what it takes to obtain design protection and how this IP

Read more...

Mobile Sliding Menu